Arkios BioDevelopment International
will help you achieve your final goal from strategic planning to either a successful approval for your Investigational New Drug (IND) or Investigational Device Exemption (IDE) with the FDA.

From Strategic Planning to your Final Submission, we can help you

Contact us to help you get started on the right track.

STEP 1	STEP 2	STEP 3	STEP 4	STEP 5	STEP 6
STRATEGIC PLANNING	PRECLINICAL TESTING	APPLICATION PROCESS	CLINCIAL TRIALS Phases 1, 2, 3	FDA SUBMISSION	FDA APPROVAL or MARKET CLEARANCE